Indo-MIM IPO closes on Monday, July 27, 2026 — and if you have not applied yet, today and Monday are your last two chances. With subscription at 3.07x overall and NII leading at 8.44x, the IPO has seen healthy but not overwhelming demand. The GMP has eased from its peak of +₹195 to around +₹155 — which has made some investors nervous. Should you still apply on the last day? Here is the complete picture.
Indo-MIM IPO — Current Status (As of July 25, 2026)
- Subscription Status: 3.07x overall
- QIB (Qualified Institutional Buyers): 1.11x
- NII / HNI (Non-Institutional): 8.44x
- Retail Individual Investors: 1.89x
- Employee Quota: 1.87x
- GMP Today: +₹155 (+32%) — Est. Listing ~₹640
- IPO Closes: July 27, 2026 (Monday)
- Allotment: July 28, 2026
- Listing Date: July 30, 2026 (BSE & NSE)
Why Is Indo-MIM IPO GMP Falling?
This is the most common question being asked right now. The GMP peaked at +₹195 (+40%) before the IPO opened and has since eased to +₹155 (+32%). Here is why this happens — and why it does not necessarily mean the IPO is going bad:
1. GMP Naturally Cools as IPO Nears Close
Grey market operators who bought shares at +₹195 GMP (expecting a big listing) begin booking profits as the IPO closes. This selling pressure in the grey market brings GMP down even if fundamentals have not changed. It is a normal pattern seen in almost every IPO — peak GMP before/on Day 1, gradual easing through Day 3. It reflects grey market profit-taking, not a change in the company's outlook.
2. Large OFS Component Creates Caution
Indo-MIM's ₹3,811 Cr issue has a significant OFS portion (₹3,312 Cr of the total). This means existing shareholders — including private equity investors — are cashing out a large portion at the IPO price. Sophisticated investors in the grey market factor this in, which caps the GMP upside compared to a 100% fresh issue IPO.
3. QIB Subscription Still Low at 1.11x
QIB subscription at 1.11x after Day 2 is the one number worth watching. Institutional investors (mutual funds, FIIs, insurance companies) typically do their bulk buying on Day 2 and Day 3. If QIB closes at 2–3x or higher, it signals strong institutional conviction and usually results in a much better listing. If QIB stays below 2x, it suggests institutions are cautious on valuation. Monday's final QIB numbers will be the key data point.
The Case FOR Applying on Last Day
- GMP at +32% is still strong — even at +₹155, the estimated listing is ~₹640 vs issue price ₹485. That is a meaningful gain.
- Retail at 1.89x means allotment probability is decent — in a 2x retail oversubscribed IPO, roughly 1 in 2 retail applicants get allotment. Much better odds than a 50x oversubscribed SME IPO.
- NII at 8.44x shows HNI investors are heavily committed — when large investors with access to more research are bidding aggressively, it is a positive signal.
- Fundamentals unchanged — revenue +28%, PAT +26% in FY26, world's largest MIM company, 1,100+ customers in 50 countries. None of this has changed since the IPO opened.
- Listing day is July 30 — only 3 trading days away. The grey market will reprice rapidly in the pre-open session on listing day based on final subscription and market conditions.
The Case AGAINST Applying on Last Day
- QIB at 1.11x is a yellow flag — if institutions do not show up strongly on Day 3, the listing could disappoint relative to GMP expectations.
- Large OFS means promoters/PE are selling — ₹3,312 Cr of existing shares coming to market is a meaningful overhang.
- GMP declining trend — from +₹195 to +₹155 in 3 days. If this trend continues, actual listing could be closer to +15–20% rather than +32%.
- Broader market risk — any Nifty correction over the weekend could dampen listing sentiment on July 30.
What Typically Happens to QIB on Last Day?
This is important to understand. In most mainboard IPOs, QIB subscription surges dramatically on the final day. Institutional investors often wait until the last few hours of Day 3 to submit bids — this allows them to assess overall demand before committing. A QIB category at 1.11x on Day 2 can easily close at 5–10x by end of Day 3 (Monday 5 PM). This is the single most important number to watch on July 27.
If QIB closes above 3x: Expect listing closer to +35–40% (near previous GMP highs). Strong institutional validation.
If QIB closes between 1–2x: Listing likely in the +15–25% range. Decent but not spectacular.
If QIB closes below 1x: Rare but possible if institutions find valuation too high — listing could disappoint significantly.
Allotment Probability for Retail Investors
With retail subscription at 1.89x as of Day 2, the current allotment probability is approximately 1 in 2 (50%) for retail applicants. However, this number will change on Day 3 as more retail bids come in — especially from investors who waited to see the subscription trend.
If retail closes at 3–5x: Allotment probability drops to 1 in 3–5. Still manageable.
If retail closes at 10x+: Allotment probability below 1 in 10 — apply only if you are comfortable with likely no-allotment.
Strategy: Apply at cut-off price (₹485) for 1 lot (30 shares, ₹14,550). This maximises allotment probability in the computerised lottery.
How to Apply for Indo-MIM IPO — Last Day Guide
- Open your broker app: Zerodha, Groww, Angel One, Upstox, HDFC Sky, Paytm Money
- Search 'Indo-MIM IPO' in the IPO section
- Select price: Apply at Cut-off Price (₹485 per share)
- Select quantity: 1 lot = 30 shares (Min investment ₹14,550)
- Submit UPI mandate and APPROVE it within 30 minutes — unapproved mandates mean rejected applications
- Last day deadline: Applications must be submitted by 5:00 PM on Monday July 27, 2026
- Check allotment: July 28 via MUFG Intime registrar website or BSE IPO allotment page
Our Verdict — Should You Apply on Last Day?
YES — Apply, but go in with realistic expectations.
The fundamentals of Indo-MIM remain strong — world's largest MIM company, consistent growth, global customer base. The GMP at +32% still implies a meaningful listing gain even if it does not reach the earlier highs of +40%.
The key risk is QIB subscription. Watch the Day 3 numbers on Monday. If QIB crosses 3x by afternoon, that is a strong green signal. If QIB is still sluggish, temper your listing expectations.
For long-term investors: The short-term GMP movement is noise. Indo-MIM's 10-year story — precision components for auto, aerospace, defence, medical, and EV industries globally — remains intact. If you did not get allotment or want more exposure, consider buying on listing day if the stock lists at a reasonable premium and does not spike to irrational levels.
- Apply: YES — at cut-off price (₹485), 1 lot minimum
- Expected listing: ₹620–₹660 (based on current GMP trend)
- Watch: QIB Day 3 subscription number on Monday afternoon
- Listing date: July 30, 2026 (Wednesday)
- Check allotment: July 28 at ipolyst.com or MUFG Intime registrar
Disclaimer
Disclaimer: This article is for informational and educational purposes only and does not constitute financial advice. IPOLyst is not a SEBI-registered investment advisor. GMP data is sourced from grey market operators and is indicative only. Subscription data is as of July 24, 2026 end of day. Final subscription numbers will be published after July 27 close. Please consult a qualified financial advisor before making any investment decisions.